Sixto Pacheco, President and CEOThis success in the domain stems from BCW’s simple yet powerful philosophy—never overpromise and underdeliver. An unwavering commitment to honesty and reliability has earned it a reputation as a trusted partner in the industry. If the BCW team is unable to fulfill a request, they are upfront about it. These principles are fundamental to its strong foundation in the industry today.
BCW is dedicated to meeting the unique needs of each client, offering support and tailored solutions at every stage of the research cycle, from project initiation to completion. The R&D process typically comprises five stages: planning, research, development, testing, and marketing and product release. Whether clients require support throughout the cycle or at specific stages of their research, BCW is committed to providing tailored solutions to meet their unique needs.
One of the areas it specializes in is the testing phase of pharmaceutical R&D, offering a comprehensive suite of services to support this critical stage. The resources include qualified sites for various specimen conditions, temperature-controlled shipping logistics, a certified in-house testing laboratory, and a temperature-controlled biorepository. These components are tied together by a comprehensive quality program, which ensures the highest quality at every level. BCW also places a strong emphasis on quality assurance, training its staff to maintain the quality clients expect. This commitment to quality is particularly evident in its biorepository services, where complete validations of all freezers and redundant systems are used to ensure quality control and assurance.
“We recognize the critical role diagnostic specimens play in advancing R&D in the in-vitro and molecular fields. That’s why our testing laboratory focuses on esoteric and molecular testing methodologies in the infectious diseases testing arena. This specialized focus allows us to offer a wide range of advanced testing capabilities to meet the specific needs of clients in these fields,” says Sixto Pacheco, president and CEO of BCW.
For instance, when a client requested samples of the IgM antibody against Hepatitis A, BCW’s team sprang into action. It monitored epidemiological data closely and discovered an outbreak occurring in the U.S. Despite the urgency of the situation, BCW obtained IRB approval and established a new facility in less than two weeks. Thanks to this swift response, it could identify and inform potential victims of the infection, taking critical steps to curb the outbreak. Its team located the affected area, obtained samples from locals, and delivered them quickly and efficiently to the client.
We recognize the critical role diagnostic specimens play in advancing R&D in the in-vitro and molecular fields. That’s why our testing laboratory focuses on esoteric and molecular testing methodologies in the infectious diseases testing arena
Apart from its diverse range of testing competencies, BCW’s flexibility enables it to adapt quickly to changing circumstances and better prepare for future challenges. For instance, the COVID-19 pandemic dealt a severe blow to the logistics and supply chain departments of the pharmaceutical industry, causing significant transportation disruptions and leading to shortages of critical samples. To address these challenges, BCW implemented creative shipping solutions tailored to the needs of each specimen being transported. From the moment a specimen left a client’s location, they could rest assured it was in the hands of BCW’s expert team, dedicated to delivering reliable and temperature-controlled shipping.
BCW’s success can be attributed to the 3 Ps—people, process, and products. Since its establishment, the main objective has been to exceed customer expectations and meet unique needs. As it continues to grow internationally and evolve, BCW remains dedicated to maintaining its commitment to excellence and providing the highest quality services to clients in need.
